| |
Matthew A. Gibbs
General Partner
Boston, MA
mgibbs@oxbio.com |
Mr. Gibbs joined Oxford Bioscience Partners in 1997. He has 14 years of investing experience in the healthcare and technology venture industry. Prior to joining Oxford, Mr. Gibbs was with The Venture Fund of Washington, a healthcare venture capital firm. Previously, he was with MedVest, Inc., a venture capital syndicated fund with Johnson & Johnson Development Corporation, Oak Investment Partners and Marquette Venture Partners. Mr. Gibbs received his B.A. from the University of Colorado and completed Executive Programs from Harvard Business School.
Mr. Gibbs led the firm's investments in Luca Technologies (bio-energy); Zettacore Inc (molecular memory); Intechra Corp (e-waste security); Zone Labs (security software) acquired by CheckPoint Software (Nasdaq: CHKP); BioSource (lifescience reagents) acquired by Invitrogen (Nasdaq: IVGN); Stratagene (lifescience instruments and reagents) acquired by Agilent (NYSE: A). Mr. Gibbs lives in Boston with his wife and twin daughters.
Back to OBP Team
|
|